The influence of pretransplant interferon-α therapy on survival after allogenous BMT in patients with CML.

被引：0
|
作者：
Hochhaus, A [1 ]
Kolb, HJ [1 ]
Hasford, J [1 ]
Berger, U [1 ]
Muth, A [1 ]
Pfirrmann, M [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Med Klin, Mannheim, Germany
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
191
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [41] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Koudriavtseva, T.
    Plantone, D.
    Renna, R.
    Mandoj, C.
    Mainero, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 288 - 289
  • [42] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Koudriavtseva, T.
    Plantone, D.
    Renna, R.
    Mandoj, C.
    Mainero, C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E309 - E309
  • [43] Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis
    Emilio Portaccio
    Maria Pia Amato
    CNS Drugs, 2009, 23 : 453 - 462
  • [44] Interferon-β gene therapy improves survival in an immunocompetent mouse model of carcinomatosis
    Hendren, SK
    Prabakaran, I
    Buerk, DG
    Karakousis, G
    Feldman, M
    Spitz, F
    Menon, C
    Fraker, DL
    SURGERY, 2004, 135 (04) : 427 - 436
  • [45] Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis
    Portaccio, Emilio
    Amato, Maria Pia
    CNS DRUGS, 2009, 23 (06) : 453 - 462
  • [46] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Tatiana Koudriavtseva
    Domenico Plantone
    Rosaria Renna
    Chiara Mandoj
    Diana Giannarelli
    Caterina Mainero
    Neurological Sciences, 2015, 36 : 2263 - 2268
  • [47] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Koudriavtseva, Tatiana
    Plantone, Domenico
    Renna, Rosaria
    Mandoj, Chiara
    Giannarelli, Diana
    Mainero, Caterina
    NEUROLOGICAL SCIENCES, 2015, 36 (12) : 2263 - 2268
  • [48] Combinations of alpha-2b interferon (INF) with hydroxyurea or cytarabine have equivalent effects on survival in early chronic phase CML.
    Giles, FJ
    Chen, S
    Jootar, S
    Advani, SH
    Rappaport, BL
    Wong, GC
    Caviles, AP
    Aziz, Z
    Fahed, Z
    Aydogdu, I
    Supandiman, I
    BLOOD, 1999, 94 (10) : 274B - 274B
  • [49] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [50] Influence of an interferon-β therapy on oligodendrocyte proliferation and differentiation by sera from untreated and treated MS patients
    Kotsiari, A.
    Voss, E.
    Pul, R.
    Skripuletz, T.
    Ragancokova, D.
    Stangel, M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S202 - S203
12345